and sample dilution (6). It is commonly accepted that the protein-CBB dye complex is soluble under assay conditions, but our studies reveal loss of color yield after microfugation or filtration of assay tubes containing protein standard or human urine. Procipitation ofthe complex occurs immediately after dye reagent is added and could cause problems in automated analysis.
The CBB dye reagents were prepared as recommended (1, 7, 8) or purchased from Bio-Rad Labs. (Richmond, CA). The increase in absorbance (A595 or Aem) was measured against a reagent blank after 10 mm with a Jenway Model 6100 spectrophotometer (Dunmow, UK). The assay mixtures were then microfuged (13 400 x g, 5 mm; M.S.E. Micro Centaur Centrifuge, Loughborough, UK) or filtered (0.2 pm; Minsart ifiter unit, Sartorius, Belmont, UK) and absorbance measurements were repeated on the respective supernatants and filtrates. The assay protocols were as follows:
. The methods we assessed were those of (a) Chirgwin et al. RNA amplification was carried out with the commercial primers DM151 (5'-GTCTCTGAATCAGAAATCCT-TCTATC-3') and DM152 (5'-CATGT-CAAATTTCACTGCTTCATCC-3'), which amplify a 420-bp sequence from IL-la mRNA (3); IL-la mENA was used as control template (purchased from Perkin-Elmer Cetus Corp., Norwalk, CT). The negative controls were positive either in the amplification or reamplification assays (negative controls were done as a DNA amplification for RNA samples).
Only when the RNA samples were treated with DNASe did negative controls stay negative. These results suggest that even a final oligo(dT) affinity-coluinn purification of mRNA cannot provide mRNA of sufficient purity for direct RNA amplification without a previous DNASe treatment.
In conclusion, we believe that RNA amplification procedures must include DNASe pretreatment even when DNA is undetectable.
